Skip to main content
Year archive

Luye Pharma Group Limited — 2025 filings

All 87 regulatory filings released by Luye Pharma Group Limited (2186) in 2025, sourced directly from the official regulator.

87 Filings
2025 Period
2025 filings (87)
Filing Released Lang
Terms of Reference for Nomination Committee of the board of directors of the Company
Governance Information
2025-12-31 English
APPOINTMENT OF NOMINATION COMMITTEE MEMBER
Board/Management Information
2025-12-31 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2025-12-31 English
DISCLOSEABLE TRANSACTIONS TRANSFER OF 25% INTEREST IN NANJING LUYE AND RELATED TRANSACTIONS
Regulatory Filings
2025-12-28 English
VOLUNTARY ANNOUNCEMENT THE GRANT OF EXCLUSIVE COMMERCIALIZATION RIGHTS TO NHWA FOR THREE LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN THE CHINESE MAINLAND
Regulatory Filings
2025-12-24 English
DISCLOSEABLE TRANSACTION COMPLETION OF THE ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Capital/Financing Update
2025-12-12 English
VOLUNTARY ANNOUNCEMENT THE GROUP'S FIVE NEW PRODUCTS INCLUDED IN CHINA'S 2025 NATIONAL REIMBURSEMENT DRUG LIST OR COMMERCIAL INSURANCE INNOVATIVE DRUG LIST
Regulatory Filings
2025-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Regulatory Filings
2025-12-03 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement
2025-12-03 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement
2025-12-03 English
Interim Report 2025
Interim / Quarterly Report H1 2025
2025-12-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-12-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2025
Interim / Quarterly Report H1 2025
2025-11-25 English
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03017 FOR CLINICAL TRIALS IN THE U.S.
Regulatory Filings
2025-11-24 English
DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Capital/Financing Update
2025-11-21 English
POSITIVE PROFIT ALERT
Earnings Release H1 2025
2025-11-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings
2025-11-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-11-03 English
NOTICE OF BOARD MEETING
Regulatory Filings
2025-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change
2025-10-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-10-02 English
Interim Report 2025
Interim / Quarterly Report H1 2025
2025-09-29 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-09-10 English
OVERSEAS REGULATORY ANNOUNCEMENT
Share Issue/Capital Change
2025-09-10 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-09-09 English
OVERSEAS REGULATORY ANNOUNCEMENT
Share Issue/Capital Change
2025-09-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings
2025-09-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-09-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report H2 2025
2025-08-28 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-20 English
OVERSEAS REGULATORY ANNOUNCEMENT
Share Issue/Capital Change
2025-08-20 English
NOTICE OF BOARD MEETING
Report Publication Announcement
2025-08-18 English
VOLUNTARY ANNOUNCEMENT PATIENT ENROLLMENT COMPLETED FOR THE PHASE III CLINICAL STUDY OF RUOXINLIN IN CHINA FOR TREATING GENERALIZED ANXIETY DISORDER
Regulatory Filings
2025-08-18 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 AUGUST 2025
Declaration of Voting Results & Voting Rights Announcements
2025-08-15 English
OVERSEAS REGULATORY ANNOUNCEMENT
Share Issue/Capital Change
2025-08-14 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-14 English
BAD WEATHER ARRANGEMENT FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 15 AUGUST, 2025
Regulatory Filings
2025-08-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Regulatory Filings
2025-08-04 English
Next Day Disclosure Return
Share Issue/Capital Change
2025-08-01 English
OVERSEAS REGULATORY ANNOUNCEMENT
Share Issue/Capital Change
2025-08-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-08-01 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024/25
Environmental & Social Information
2025-07-22 English
Annual Report 2024/25
Annual Report FY 2025
2025-07-22 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement
2025-07-22 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement
2025-07-22 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on Friday, 15 August 2025 at 10:00 a.m.
Proxy Solicitation & Information Statement
2025-07-22 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-07-22 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; RE-APPOINTMENT OF INDEPENDENT AUDITOR&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-07-22 English
Terms of Reference for the Nomination Committee (amended and adopted by the Board on 17 July 2025)
Governance Information
2025-07-17 English
SUPPLEMENTAL ANNOUNCEMENT - APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2025-07-16 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings
2025-07-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2025
Earnings Release FY 2025
2025-06-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
Regulatory Filings
2025-06-05 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2024
Regulatory Filings
2025-06-04 English
List of Directors and their Roles and Functions
Governance Information
2025-06-03 English
RESIGNATION OF DIRECTOR
Board/Management Information
2025-06-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-06-03 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2025
Declaration of Voting Results & Voting Rights Announcements
2025-05-28 English
DATE OF BOARD MEETING
Report Publication Announcement
2025-05-19 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-05-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings
2025-05-07 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2025-04-29 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2025
Proxy Solicitation & Information Statement
2025-04-29 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTOR WHO HAS SERVED MORE THAN NINE YEARS ON THE BOARD
Proxy Solicitation & Information Statement
2025-04-29 English
Environmental, Social and Governance Report 2024
Environmental & Social Information
2025-04-29 English
Annual Report 2024
Annual Report FY 2024
2025-04-29 English
VOLUNTARY ANNOUNCEMENT ROTIGOTINE LUYE TRANSDERMAL PATCH LAUNCHED IN THE UNITED KINGDOM
Regulatory Filings
2025-04-10 English
VOLUNTARY ANNOUNCEMENT CLASS 1 INNOVATIVE ANTIDEPRESSANT RUOXINLIN APPROVED FOR MARKETING IN MACAO
Regulatory Filings
2025-04-07 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2025-04-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings
2025-04-02 English
VOLUNTARY ANNOUNCEMENT RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN JAPAN
Regulatory Filings
2025-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release FY 2024
2025-03-30 English
CLARIFICATION ANNOUNCEMENT IN RELATION TO THE INTERIM RESULTS ANNOUNCEMENT AND THE INTERIM REPORT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Regulatory Filings
2025-03-25 English
NOTICE OF BOARD MEETING
Board/Management Information
2025-03-14 English
CHANGE OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2025-03-10 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2025-03-10 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings
2025-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Regulatory Filings
2025-02-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-02-04 English
List of Directors and their Roles and Functions
Board/Management Information
2025-01-20 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information
2025-01-20 English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA
Regulatory Filings
2025-01-15 English
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03020 FOR CLINICAL TRIALS IN THE U.S.
Regulatory Filings
2025-01-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2025-01-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings
2025-01-02 English